Research Update for ER-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

preview_player
Показать описание
Daniel Abravanel, MD, PhD; Erica Mayer, MD, MPH; and Elahe Salehi, DNP; discuss advances in research and treatment for patients with ER-positive metastatic breast cancer.
  1. Dana-Farber Cancer Institute
  2. Dana-Farber Cancer Institute
  3. DFCI
  4. Dana-Farber
  5. cancer
  6. Metastatic Breast Cancer
Рекомендации по теме
ER-Positive MBC Research 0:57:42

ER-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series

Research Update for 1:01:07

Research Update for ER-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Research Update for 1:00:38

Research Update for ER-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Research Update for 0:58:31

Research Update for ER-Positive MBC | 2023-2024 EMBRACE MBC Virtual Forum Series

Triple Negative MBC 1:00:19

Triple Negative MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series

HER2-Positive MBC Research 0:58:36

HER2-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series

Research Update for 1:00:41

Research Update for HER2-Positive MBC | 2023-2024 EMBRACE MBC Virtual Forum Series

Research Update for 0:59:33

Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Medical Update: Hormone 1:14:32

Medical Update: Hormone Receptor-Positive Metastatic Breast Cancer

Report Back from 0:59:35

Report Back from ASCO 2024: Latest Updates on Metastatic Breast Cancer (MBC)

2021 San Antonio 0:59:15

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Research Update for 0:56:42

Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Research Update for 1:01:54

Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

SERD vs investigator’s 0:04:39

SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC

ER-Positive Breast Cancer: 0:59:39

ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019

ELAINE 1: LAS 0:05:47

ELAINE 1: LAS vs fulv in la ER+/HER2- mBC ESR1m + disease progression on AI and CDK4/6i inhibitors

Research Update for 1:07:16

Research Update for Triple Negative MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Palbociclib shows improved 0:06:38

Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Welcome Session | 1:16:41

Welcome Session | 2024-2025 EMBRACE MBC Virtual Forum Series

Treatment Updated for 0:30:57

Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

PUCCINI: early metabolic 0:04:17

PUCCINI: early metabolic response predicts survival in patients with mBC receiving CDK4/6 inhibitors

Breast Cancer and 0:23:52

Breast Cancer and the Immune System at MBC Patient Forum 2019

Living long term 0:52:22

Living long term with MBC: Making treatment decisions

The Ongoing Role 0:07:02

The Ongoing Role of Everolimus in ER-Positive MBC

Комментарии
Автор

Amazing thanks for the information. ...

nunomaroco